Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,051,195
+$3,439,131 QoQ
Shares Held
24,037
+417.4% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#235
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $124,492,646 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
188,515 | $102,143,081 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
345,899 | $11,719,058 | |
| 3 | ALKS |
Alkermes plc.
|
120,243 | $6,300,733 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
24,037 | $4,051,195 | |
| 5 | VTRS |
Viatris Inc
|
15,778 | $250,554 | |
| 6 | ZTS |
Zoetis Inc.
|
390 | $28,025 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,051,195 | 24,037 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $612,064 | 4,646 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $241,579,605 | 1,703,304 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $247,504,679 | 1,763,105 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $228,755,800 | 1,820,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $201,292,000 | 1,820,000 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $248,430,000 | 1,820,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $214,747,036 | 1,863,800 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $261,385,768 | 1,898,640 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $283,546,142 | 2,055,874 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $320,242,680 | 2,430,500 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $290,649,375 | 2,583,550 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $246,387,040 | 2,612,800 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $264,518,226 | 2,613,300 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $331,242,235 | 2,773,294 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $303,245,055 | 2,855,146 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $277,262,850 | 2,844,305 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $283,448,531 | 3,023,451 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $270,887,528 | 3,180,551 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $288,118,531 | 3,004,051 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $293,687,527 | 3,017,751 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $318,450,084 | 3,274,551 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $325,568,998 | 3,396,651 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $317,082,888 | 3,297,451 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $391,729,800 | 3,210,900 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $282,107,474 | 3,259,474 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||